Home > Insider Trading > Filing (0001209191-20-004627)

Filing Details

Accession Number:: 0001209191-20-004627
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-01-23 16:06:51
Reporting Period:: 2020-01-21

Accepted Time:: 2020-01-23 16:06:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
718937	Staar Surgical Co	STAA	Ophthalmic Goods (3851)	953797439

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1325697	J Deborah Andrews	25651 Atlantic Ocean Drive Lake Forest CA 92630	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-01-21	20,000	$11.00	52,101	No	4	M	Direct
Common Stock	Acquisiton	2020-01-21	20,000	$5.34	72,101	No	4	M	Direct
Common Stock	Acquisiton	2020-01-21	10,000	$15.54	82,101	No	4	M	Direct
Common Stock	Acquisiton	2020-01-21	15,000	$7.35	97,101	No	4	M	Direct
Common Stock	Acquisiton	2020-01-21	9,000	$7.36	106,101	No	4	M	Direct
Common Stock	Acquisiton	2020-01-21	4,583	$9.30	110,684	No	4	M	Direct
Common Stock	Acquisiton	2020-01-21	17,360	$15.25	128,044	No	4	M	Direct
Common Stock	Acquisiton	2020-01-21	7,291	$16.15	135,335	No	4	M	Direct
Common Stock	Acquisiton	2020-01-21	3,370	$29.80	138,705	No	4	M	Direct
Common Stock	Disposition	2020-01-21	106,604	$42.20	32,101	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Options	Disposition	2020-01-21	20,000	$0.00	20,000	$11.00
Common Stock	Common Stock Options	Disposition	2020-01-21	20,000	$0.00	20,000	$5.34
Common Stock	Common Stock Options	Disposition	2020-01-21	10,000	$0.00	10,000	$15.54
Common Stock	Common Stock Options	Disposition	2020-01-21	15,000	$0.00	15,000	$7.35
Common Stock	Common Stock Options	Disposition	2020-01-21	9,000	$0.00	9,000	$7.36
Common Stock	Common Stock Options	Disposition	2020-01-21	4,583	$0.00	4,583	$9.30
Common Stock	Common Stock Options	Disposition	2020-01-21	17,360	$0.00	17,360	$15.25
Common Stock	Common Stock Options	Disposition	2020-01-21	7,291	$0.00	7,291	$16.15
Common Stock	Common Stock Options	Disposition	2020-01-21	3,370	$0.00	3,370	$29.80

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2022-03-01	No	4	M	Direct
0	2023-03-03	No	4	M	Direct
0	2024-03-06	No	4	M	Direct
0	2025-04-06	No	4	M	Direct
0	2026-04-03	No	4	M	Direct
139	2027-03-20	No	4	M	Direct
695	2027-11-12	No	4	M	Direct
347	2028-03-14	No	4	M	Direct
188	2021-06-13	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.86 to $42.53, inclusive.
These stock options became exercisable in three equal annual installments on March 4, 2014, March 4, 2015, and March 4, 2016.
These stock options became exercisable in three equal annual installments on March 2, 2013, March 2, 2014, and March 2, 2015.
These stock options became exercisable in three equal annual installments on March 7, 2015, March 7, 2016, and March 7, 2017.
These stock options became exercisable in three equal annual installments on April 7, 2016, April 7, 2017, and April 7, 2018.
The options granted became exercisable as follows: 1/3 on 04/04/2017, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted became exercisable on 04/04/2019.
The options granted become exercisable as follows: 1/3 on 03/21/2018, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 03/21/2020.
The options granted become exercisable as follows: 1/3 on 11/13/2018, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 11/13/2020.
The options granted become exercisable as follows: 1/3 on 03/15/2019, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 03/15/2021.
The options granted become exercisable as follows: 1/3 on 06/14/2019, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 06/14/2021.